Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects.
Zhang H, Li Q, Zhu X, Li C, Li X, Liu C, Hu Y, Chen G, Wei H, Wang J, Shen Z, Ding Y.
Zhang H, et al. Among authors: li c, li x, li q.
Cancer Chemother Pharmacol. 2018 Oct;82(4):615-623. doi: 10.1007/s00280-018-3645-1. Epub 2018 Jul 24.
Cancer Chemother Pharmacol. 2018.
PMID: 30043208
Clinical Trial.